Robert Blazej is a dedicated biotechnologist currently serving as a Partner at Mission BioCapital. With extensive expertise in life-science research, business operations, and intellectual property, Robert contributed to significant genome projects at Lawrence Berkeley National Labs and the Fred Hutchinson Cancer Research Center early in their career. They co-founded Allopartis Biotechnologies and served as CEO until its acquisition by Novozymes in 2013, followed by a role as Managing Director at Novozymes' San Francisco site. Since 2017, Robert has been instrumental in supporting life-science startups through their executive roles at various organizations. Robert earned a Ph.D. from the University of California, Berkeley.
Location
San Francisco, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices